R.M. Rudd

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

M.H. Cullen, Lucinda Billingham, C.M. Woodroffe et al. · Journal of Clinical Oncology · 1999 · 448 citations

p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus

V. Sundaresan, Peter Ganly, P S Hasleton et al. · Lung Cancer · 1993 · 259 citations

Preinvasive Lesions, Medicine, Pathology +8

Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.

R.M. Rudd, P L Haslam, M Turner‐Warwick · PubMed · 1981 · 247 citations

Asthma, Inflammatory Lung Disease, Advanced Lung Disease +18

British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society

R.J. Prescott, J C Chalmers, R.M. Rudd · Thorax · 1997 · 205 citations · Full text

Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy

R L Souhami, SG Spiro, R.M. Rudd et al. · JNCI Journal of the National Cancer Institute · 1997 · 203 citations · Full text